Image-Guided Therapy Systems

Global Image-Guided Therapy Systems Market to Reach US$4.6 Billion by 2030

The global market for Image-Guided Therapy Systems estimated at US$3.3 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Magnetic Resonance Imaging segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$904.9 Million While China is Forecast to Grow at 5.2% CAGR

The Image-Guided Therapy Systems market in the U.S. is estimated at US$904.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$711.6 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Image-Guided Therapy Systems Market - Key Trends and Drivers Summarized

Why Are Image-Guided Therapy Systems Vital for Precision Medicine?

Image-guided therapy systems have emerged as an essential tool in precision medicine by enabling real-time imaging during therapeutic interventions. These systems use modalities such as MRI, CT, and ultrasound to provide continuous visual feedback during procedures, allowing healthcare professionals to precisely target affected areas while minimizing damage to surrounding tissues. Image-guided therapy is particularly valuable in oncology, cardiology, and neurology, where the ability to monitor and adjust treatment in real time leads to better outcomes. The integration of advanced imaging technologies with therapeutic systems is reducing complications, shortening recovery times, and enhancing the overall efficacy of treatments, making image-guided therapy indispensable in modern medicine.

What Technological Advancements Are Shaping Image-Guided Therapy Systems?

Technological innovations in imaging resolution, real-time data processing, and minimally invasive therapeutic techniques are enhancing the capabilities of image-guided therapy systems. High-resolution imaging modalities, such as 3D MRI and CT, provide detailed anatomical visualizations, enabling clinicians to accurately target tumors or lesions. Real-time image processing systems are now equipped with AI-driven software that can quickly analyze data, allowing for rapid decision-making during procedures. Additionally, the development of minimally invasive tools, such as catheter-based interventions and laser ablation devices, has been integrated with image-guided systems, making complex procedures more accessible and reducing patient recovery times. These advancements are elevating the precision and effectiveness of treatments across various medical fields.

How Do Market Segments Define Growth in the Image-Guided Therapy Systems Market?

Technologies include MRI-guided systems, CT-guided systems, and ultrasound-guided systems, with MRI-guided therapy being one of the most widely used due to its high precision in visualizing soft tissues. Applications span across oncology, cardiology, neurology, and orthopedics, with oncology holding the largest market share as image-guided therapy is frequently used in cancer treatments such as radiation therapy and tumor ablation. End-users include hospitals, ambulatory surgical centers, and specialized clinics, with hospitals dominating the market due to their advanced infrastructure and higher patient volumes. The increasing use of image-guided therapy in outpatient settings is also contributing to market growth.

What Factors Are Driving the Growth in the Image-Guided Therapy Systems Market?

The growth in the image-guided therapy systems market is driven by several factors, including advancements in imaging technologies, the rising prevalence of chronic diseases, and increasing demand for minimally invasive procedures. As imaging technologies continue to evolve, providing clearer and more accurate real-time visualizations, healthcare providers are increasingly adopting image-guided therapy systems to improve treatment outcomes. The growing incidence of cancer, cardiovascular diseases, and neurological disorders is also fueling demand for precise, targeted therapies that reduce complications and enhance patient recovery. Additionally, the shift towards minimally invasive techniques is driving the use of image-guided systems, which offer reduced surgical risks and shorter recovery times, making them an attractive option for both patients and healthcare providers.

SCOPE OF STUDY:

The report analyzes the Image-Guided Therapy Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Endoscopes, Magnetic Resonance Imaging, Ultrasound Systems, Computed Tomography (CT) Scanners, Other Product Types); Application (Cardiac Surgery, Urology, Oncology Surgery, Gastroenterology, Neurosurgery, Orthopedic Surgery, Other Applications); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

• Analogic Corporation
• Brainlab
• Canon Medical Systems Corporation
• Fujifilm Holdings Corporation
• General Electric
• Koninklijke Philips N.V.
• Medtronic
• Siemens Ag
• Stryker
• Varian Medical Systems, Inc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.